A detailed history of Sabby Management, LLC transactions in Biovie Inc. stock. As of the latest transaction made, Sabby Management, LLC holds 689,135 shares of BIVI stock, worth $310,110. This represents 12.47% of its overall portfolio holdings.

Number of Shares
689,135
Holding current value
$310,110
% of portfolio
12.47%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$0.53 - $1.89 $365,241 - $1.3 Million
689,135 New
689,135 $365,000
Q3 2022

Nov 14, 2022

SELL
$1.38 - $3.61 $730,464 - $1.91 Million
-529,322 Reduced 84.37%
98,048 $244,000
Q2 2022

Aug 15, 2022

BUY
$1.44 - $5.04 $20,816 - $72,858
14,456 Added 2.36%
627,370 $910,000
Q1 2022

May 16, 2022

SELL
$2.74 - $5.65 $96,806 - $199,620
-35,331 Reduced 5.45%
612,914 $2.89 Million
Q4 2021

Feb 14, 2022

BUY
$4.41 - $6.99 $632,323 - $1 Million
143,384 Added 28.4%
648,245 $2.92 Million
Q3 2021

Nov 15, 2021

BUY
$6.69 - $16.93 $3.38 Million - $8.55 Million
504,861 New
504,861 $3.38 Million

Others Institutions Holding BIVI

About BIOVIE INC.


  • Ticker BIVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,165,300
  • Market Cap $13.6M
  • Description
  • BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...
More about BIVI
Track This Portfolio

Track Sabby Management, LLC Portfolio

Follow Sabby Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sabby Management, LLC with notifications on news.